Correlation Between Intellia Therapeutics and Arcus Biosciences
Can any of the company-specific risk be diversified away by investing in both Intellia Therapeutics and Arcus Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Intellia Therapeutics and Arcus Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Intellia Therapeutics and Arcus Biosciences, you can compare the effects of market volatilities on Intellia Therapeutics and Arcus Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Intellia Therapeutics with a short position of Arcus Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Intellia Therapeutics and Arcus Biosciences.
Diversification Opportunities for Intellia Therapeutics and Arcus Biosciences
0.51 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Intellia and Arcus is 0.51. Overlapping area represents the amount of risk that can be diversified away by holding Intellia Therapeutics and Arcus Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Arcus Biosciences and Intellia Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Intellia Therapeutics are associated (or correlated) with Arcus Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Arcus Biosciences has no effect on the direction of Intellia Therapeutics i.e., Intellia Therapeutics and Arcus Biosciences go up and down completely randomly.
Pair Corralation between Intellia Therapeutics and Arcus Biosciences
Given the investment horizon of 90 days Intellia Therapeutics is expected to under-perform the Arcus Biosciences. But the stock apears to be less risky and, when comparing its historical volatility, Intellia Therapeutics is 1.04 times less risky than Arcus Biosciences. The stock trades about -0.05 of its potential returns per unit of risk. The Arcus Biosciences is currently generating about 0.0 of returns per unit of risk over similar time horizon. If you would invest 2,107 in Arcus Biosciences on August 27, 2024 and sell it today you would lose (651.00) from holding Arcus Biosciences or give up 30.9% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Intellia Therapeutics vs. Arcus Biosciences
Performance |
| Timeline |
| Intellia Therapeutics |
| Arcus Biosciences |
Intellia Therapeutics and Arcus Biosciences Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Intellia Therapeutics and Arcus Biosciences
The main advantage of trading using opposite Intellia Therapeutics and Arcus Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Intellia Therapeutics position performs unexpectedly, Arcus Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Arcus Biosciences will offset losses from the drop in Arcus Biosciences' long position.| Intellia Therapeutics vs. Editas Medicine | Intellia Therapeutics vs. Caribou Biosciences | Intellia Therapeutics vs. Crispr Therapeutics AG | Intellia Therapeutics vs. Verve Therapeutics |
| Arcus Biosciences vs. Cullinan Oncology LLC | Arcus Biosciences vs. Annexon | Arcus Biosciences vs. Structure Therapeutics American | Arcus Biosciences vs. Relay Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Other Complementary Tools
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |